chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Major depression, Pneumonia aspiration, SARS-CoV-2 test positive, Sepsis, Speech disorder developmental
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "80 YO female with PMH of drug induced parkinsons, depression, hypertension, breast cancer who presented to the ED for chief complaint of "cant swallow." Reports this started "a few days ago", was progressive but rapidly so. Cannot state if she has had similar prior. She answers my questions in vague ways including "a while ago...you could say that...perhaps."    Patient was septic and positive for acute respiratory failure with hypoxia likely secondary to aspiration gram negative pneumonia and COVID leading to admission.  Given oxygen support, fluid resuscitation, and Rocephin leading to improvement of both progressing to normal oxygen saturation on room air and completing full course Rocephin.  Concern for stroke according to speech delay found on exam.  MRI head negative.  Speech therapy cleared patient for thick nectar, which improved to general diet.  Significant rise in troponins also found leading to diagnosis of NSTEMI.  Cardiology was referred recommending medical management with aspirin, atorvastatin 40, metoprolol tartrate 25 mg twice daily and lisinopril 40 mg daily.   Patient showed decreased appetite and flat affect consistent with major depressive disorder.  Patient had decreased appetite and body mass index of 15.  Patient and husband spoke with medicine team, stating patient would tolerate oral intake well and does not need a G-tube placed.  PT/OT met with patient recommending skilled nursing facility treatment.  Patient states she is willing to work with them.  Case Management secured placement for ongoing treatment.   Patient also reported acute near urinary retention with bladder scan greater than 300 x 2 requiring straight catheterization.  Foley catheter placed.  Flomax started.  Patient instructed to continue Foley care while at SNF and to have a voiding trial 5 days s/p discharge"
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin increased, Urinary retention
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "80 YO female with PMH of drug induced parkinsons, depression, hypertension, breast cancer who presented to the ED for chief complaint of "cant swallow." Reports this started "a few days ago", was progressive but rapidly so. Cannot state if she has had similar prior. She answers my questions in vague ways including "a while ago...you could say that...perhaps."    Patient was septic and positive for acute respiratory failure with hypoxia likely secondary to aspiration gram negative pneumonia and COVID leading to admission.  Given oxygen support, fluid resuscitation, and Rocephin leading to improvement of both progressing to normal oxygen saturation on room air and completing full course Rocephin.  Concern for stroke according to speech delay found on exam.  MRI head negative.  Speech therapy cleared patient for thick nectar, which improved to general diet.  Significant rise in troponins also found leading to diagnosis of NSTEMI.  Cardiology was referred recommending medical management with aspirin, atorvastatin 40, metoprolol tartrate 25 mg twice daily and lisinopril 40 mg daily.   Patient showed decreased appetite and flat affect consistent with major depressive disorder.  Patient had decreased appetite and body mass index of 15.  Patient and husband spoke with medicine team, stating patient would tolerate oral intake well and does not need a G-tube placed.  PT/OT met with patient recommending skilled nursing facility treatment.  Patient states she is willing to work with them.  Case Management secured placement for ongoing treatment.   Patient also reported acute near urinary retention with bladder scan greater than 300 x 2 requiring straight catheterization.  Foley catheter placed.  Flomax started.  Patient instructed to continue Foley care while at SNF and to have a voiding trial 5 days s/p discharge"
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 82.0
Sex: M
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Contracted COVID
Age: 2.92
Sex: F
Vaccine: DTAP, HEP, HEPA, VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pt had already finished the Hep B series, and the Hep B vaccine should not have been given. No immediate adverse reaction.
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: PATIENT RECEIVED BIVALENT MODERNA BOOSTER ON 01/13/2023. PATIENT RECORD HAS A RECORDED MODERNA BIVALENT BOOSTER ADMINISTERED ON 10/27/2022 BY ANOTHER FACILITY.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Energy increased, Hypertension, Laboratory test
Clinical narrative: A couple weeks after vaccine, I noticed shortness of breath, and chest tightness. This would happen with minimal exertion. After about 20 to 30 minutes it would pass, I'd then have an incredible amount of energy, that would last as long as I wanted. I researched what was happening, and found that it was somewhat common in many people. This gradually has lessoned over the past several months. I went to oral surgery and was shocked what my blood pressure reading was. I went to Dr. and we are awaiting test results. I've been monitoring my BP several times a day since then.  When I wake, my pulse is about 65, but my BP is extremely high. After an hour+ workout when my Pulse is 100+, my BP averages about 40/30 lower than when I awoke. This happens every day.  I am a very physical person.
Age: 9.0
Sex: F
Vaccine: DTAP
Symptoms: Wrong product administered
Clinical narrative: Patient was given DTAP and is 9 years of age. She should have receveid TDAP
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Diarrhoea, Feeling abnormal, Oropharyngeal pain
Clinical narrative: I did not have an adverse reaction to the vaccine. I had a persistent cough, and my throat was really sore. I tested positive for COVID-19 on 02/20/2023. I contacted my doctor and was given the prescription PAXLOVID. I had diarrhea once after taking PAXLOID but was able to get to the bathroom without any difficulty. I also had a foggy brain for a few days while taking PAXLOVID.
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I had a persistent cough, and my throat was really sore. I tested positive for COVID-19 on 02/20/2023. I contacted my doctor and was given the prescription PAXLOVID. I had diarrhea once after taking PAXLOID but was able to get to the bathroom without any difficulty. I also had a foggy brain for a few days while taking PAXLOVID.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient COVID positive after completing vaccine series.
Age: 73.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Contracted COVID
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 61.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Eczema, Rash, Rash pruritic
Clinical narrative: A couple of hours after receiving the vaccine, I've been suffering an eczema-like rash. It won't go away; it's very itchy and painful. It's located right on my collarbone on both sides. I went to urgent care where I was given a shot of hydrocortisone. I wasn't really interested in receiving any other injection since this was my first bad reaction to a vaccine. No eczema creams or anything I could find including Neosporin was aiding the itch to comfort. As of today, the rash is still present and itching.
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Blood test abnormal, Chest pain, Computerised tomogram abdomen abnormal, Factor V Leiden mutation
Clinical narrative: Patient has still never contracted COVID-19, although he has tested many times for school. He received vaccinations as soon as they became available to him in April 2021, with the second dose in May 2021. He received a booster in Nov 2021 and that led to the first adverse reaction. In Feb 2022, he had severe chest pain and he tried to rest it off but finally called home and asked advice. Since my husband had recently had an adverse reaction which led to multiple pulmonary emboli (still not having had COVID), I suggested he go to the ER and ask them to scan and see if he also had those. He went to the local Regional Medical Center and they determined he had multiple pulmonary emboli. They prescribed a blood thi
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fibrin D dimer increased, Musculoskeletal chest pain, Nasopharyngitis, Pain in extremity, Painful respiration
Clinical narrative: Patient has still never contracted COVID-19, although he has tested many times for school. He received vaccinations as soon as they became available to him in April 2021, with the second dose in May 2021. He received a booster in Nov 2021 and that led to the first adverse reaction. In Feb 2022, he had severe chest pain and he tried to rest it off but finally called home and asked advice. Since my husband had recently had an adverse reaction which led to multiple pulmonary emboli (still not having had COVID), I suggested he go to the ER and ask them to scan and see if he also had those. He went to the local Regional Medical Center and they determined he had multiple pulmonary emboli. They prescribed a blood thi
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pulmonary embolism, Splenomegaly, Ultrasound scan
Clinical narrative: Patient has still never contracted COVID-19, although he has tested many times for school. He received vaccinations as soon as they became available to him in April 2021, with the second dose in May 2021. He received a booster in Nov 2021 and that led to the first adverse reaction. In Feb 2022, he had severe chest pain and he tried to rest it off but finally called home and asked advice. Since my husband had recently had an adverse reaction which led to multiple pulmonary emboli (still not having had COVID), I suggested he go to the ER and ask them to scan and see if he also had those. He went to the local Regional Medical Center and they determined he had multiple pulmonary emboli. They prescribed a blood thi
Age: 1.75
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given one day after expiration.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Computerised tomogram thorax normal, Cough, Dyspnoea, Resuscitation
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "82-year-old female with a past medical history significant for emphysema, pulmonary fibrosis, hyperlipidemia, left subclavian stenosis, GERD, migraines with a 20 pack-year smoking history who presented to the emergency department for increased cough and shortness of breath.  The patient states she is on 5-6 L baseline and 8 L on exertion.  She was found to be COVID positive in the emergency department.  Subsequent workup unremarkable CT pulmonary also unremarkable for PE.  Patient was treated with dexamethasone 6 mg as well as continuation of her home nebulizers.  The patient did receive cefepime for 1 course, this was subsequently discontinued as patient clinical status significantly improved.  After initial resuscitation in the emergency department, patient was almost back to baseline although she was admitted and watched for 2-3 continue days.  She was agreeable to going home on 2/11/23 as she was at baseline.  Patient was discharged at her previous baseline."
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "82-year-old female with a past medical history significant for emphysema, pulmonary fibrosis, hyperlipidemia, left subclavian stenosis, GERD, migraines with a 20 pack-year smoking history who presented to the emergency department for increased cough and shortness of breath.  The patient states she is on 5-6 L baseline and 8 L on exertion.  She was found to be COVID positive in the emergency department.  Subsequent workup unremarkable CT pulmonary also unremarkable for PE.  Patient was treated with dexamethasone 6 mg as well as continuation of her home nebulizers.  The patient did receive cefepime for 1 course, this was subsequently discontinued as patient clinical status significantly improved.  After initial resuscitation in the emergency department, patient was almost back to baseline although she was admitted and watched for 2-3 continue days.  She was agreeable to going home on 2/11/23 as she was at baseline.  Patient was discharged at her previous baseline."
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Dyspnoea, Hypoxia, Pneumonia
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "82-year-old female with a past medical history significant for emphysema, pulmonary fibrosis, hyperlipidemia, left subclavian stenosis, GERD, migraines with a 20 pack-year smoking history who presented to the emergency department for increased cough and shortness of breath.  The patient states she is on 5-6 L baseline and 8 L on exertion.  She was found to be COVID positive in the emergency department.  Subsequent workup unremarkable CT pulmonary also unremarkable for PE.  Patient was treated with dexamethasone 6 mg as well as continuation of her home nebulizers.  The patient did receive cefepime for 1 course, this was subsequently discontinued as patient clinical status significantly improved.  After initial resuscitation in the emergency department, patient was almost back to baseline although she was admitted and watched for 2-3 continue days.  She was agreeable to going home on 2/11/23 as she was at baseline.  Patient was discharged at her previous baseline."
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Pneumonia bacterial, Positive airway pressure therapy, SARS-CoV-2 test positive, Sepsis, Superinfection
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "82-year-old female with a past medical history significant for emphysema, pulmonary fibrosis, hyperlipidemia, left subclavian stenosis, GERD, migraines with a 20 pack-year smoking history who presented to the emergency department for increased cough and shortness of breath.  The patient states she is on 5-6 L baseline and 8 L on exertion.  She was found to be COVID positive in the emergency department.  Subsequent workup unremarkable CT pulmonary also unremarkable for PE.  Patient was treated with dexamethasone 6 mg as well as continuation of her home nebulizers.  The patient did receive cefepime for 1 course, this was subsequently discontinued as patient clinical status significantly improved.  After initial resuscitation in the emergency department, patient was almost back to baseline although she was admitted and watched for 2-3 continue days.  She was agreeable to going home on 2/11/23 as she was at baseline.  Patient was discharged at her previous baseline."
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown. Unable to speak with case due to hospitalization. POA stated that case has been hospitalized frequently since 11/2022.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 23.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was given Bivalent Pfizer 12+ for 1st primary dose.  No treatment.  No side effects or adverse events.  Returned today for 2nd dose.  Was informed of the error and given a monovalent Pfizer 12+ as recommended.
Age: 17.0
Sex: M
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given his third Hep B dose only 4 weeks after second dose and it should have been 8 weeks.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Tinnitus
Clinical narrative: tinnitus, R ear only. last about 3 - 6 months. Did not realize how long when it resolved.  also had fever, chills, myalgia.  asymptomatic after first vaccine 1/12/2021
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Echocardiogram, Eczema nummular, Electrocardiogram ambulatory normal, Erythema, Palpitations
Clinical narrative: Heart Palpitations: Received 2 week Holter Monitor, and echo stress test.  After 4-5 months, heart palpitations went away  Red spots: on left arm (1 spot) and torso (6 or more).  Initially diagnosed as nummular eczema and given steroid cream.  Steroid cream helped, but spots came back after cream was used.  Finally, the spots have all disappeared after 5 months.
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Stress echocardiogram normal
Clinical narrative: Heart Palpitations: Received 2 week Holter Monitor, and echo stress test.  After 4-5 months, heart palpitations went away  Red spots: on left arm (1 spot) and torso (6 or more).  Initially diagnosed as nummular eczema and given steroid cream.  Steroid cream helped, but spots came back after cream was used.  Finally, the spots have all disappeared after 5 months.
Age: 74.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Feeling abnormal
Clinical narrative: I got the booster in September and in January I was tested for COVID-19 at home, I contracted from a party. I had a light floating feeling the next day and was like I was out of my body, and it was positive. I went to immediate care to get a medical test and it was positive. Fortunately, it was light duty with four days of light coughing, nasal issues and fatigue. I was only for days. My health care provider had a prescription for me but not PAXLOVID, it started with an I. It worked really great.
Age: 74.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Nasal disorder, SARS-CoV-2 test positive
Clinical narrative: I got the booster in September and in January I was tested for COVID-19 at home, I contracted from a party. I had a light floating feeling the next day and was like I was out of my body, and it was positive. I went to immediate care to get a medical test and it was positive. Fortunately, it was light duty with four days of light coughing, nasal issues and fatigue. I was only for days. My health care provider had a prescription for me but not PAXLOVID, it started with an I. It worked really great.
Age: 55.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Contusion, Erythema, Pain, Swelling
Clinical narrative: Per patient report localized swelling, redness, bruising, pain for several weeks post vaccine administration.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Headache, Pyrexia
Clinical narrative: Severe headache and mild fever
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: For this member age, the OLD workflow was 3 Monovalent Moderna vaccines (primary dose) followed by a BIVALNT dose (2 months after completion of primary dose).  The NEW workflow is 2 Monovalent Vaccines followed by a BIVALENT dose (2 months after completion of primary dose).  The nurse worked in the clinic on this day and was following the old workflow of the vaccine schedule.    Every toddler has to be observed for 15 minutes after the vaccines, no reaction reported by parents or staff.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Chills, Dyspnoea, Hypoxia, Oropharyngeal pain
Clinical narrative: Hospitalized 7/7/22-7/11/22 dyspnea, hypoxia, fever with chills, body aches, SOB, sore throat, respiratory failure, AKI, PNA,
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pneumonia, Pyrexia, Respiratory failure
Clinical narrative: Hospitalized 7/7/22-7/11/22 dyspnea, hypoxia, fever with chills, body aches, SOB, sore throat, respiratory failure, AKI, PNA,
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Fall, SARS-CoV-2 test positive
Clinical narrative: Dose #1 given 1/25/2021 Moderna lot # 004M20A Pt was i the ED 2/21/2023- due to fall, weakness, COVID +, made comfort care and died 2/22/2023 at hospital.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: The dose of DTaP that was administered expired yesterday (02/26/2023)
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal behaviour, Aphasia, Carotid artery stent insertion, Cerebrovascular accident, Computerised tomogram
Clinical narrative: Patient had CVA in July of 2022. Patient had worked that day but reports he was extra tired that evening so he went to bed early. Family members saw him that evening and determined patient was not exhibiting his normal behavior.  EMT was called and patient life flighted to hospital. Patient had surgery the following day (carotid stenting). Patient sense diagnosed with moderate aphasia. Patient is able to understand verbal language but has difficulty writing and expressing himself verbally. Patient remembers faces but unable to recall names of people he does not see on a daily basis. Patient is no longer able to drive due to a deficit in reading skills. Patient is no longer able to conduct his finances due to deficits in math skills.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dyscalculia, Dysgraphia, Fatigue, Impaired driving ability, Language disorder
Clinical narrative: Patient had CVA in July of 2022. Patient had worked that day but reports he was extra tired that evening so he went to bed early. Family members saw him that evening and determined patient was not exhibiting his normal behavior.  EMT was called and patient life flighted to hospital. Patient had surgery the following day (carotid stenting). Patient sense diagnosed with moderate aphasia. Patient is able to understand verbal language but has difficulty writing and expressing himself verbally. Patient remembers faces but unable to recall names of people he does not see on a daily basis. Patient is no longer able to drive due to a deficit in reading skills. Patient is no longer able to conduct his finances due to deficits in math skills.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Memory impairment, Reading disorder
Clinical narrative: Patient had CVA in July of 2022. Patient had worked that day but reports he was extra tired that evening so he went to bed early. Family members saw him that evening and determined patient was not exhibiting his normal behavior.  EMT was called and patient life flighted to hospital. Patient had surgery the following day (carotid stenting). Patient sense diagnosed with moderate aphasia. Patient is able to understand verbal language but has difficulty writing and expressing himself verbally. Patient remembers faces but unable to recall names of people he does not see on a daily basis. Patient is no longer able to drive due to a deficit in reading skills. Patient is no longer able to conduct his finances due to deficits in math skills.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 18.0
Sex: F
Vaccine: FLU4, MENB
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Left arm swollen, redness and warmth around injection site   patient placed on Bactrim DS 1 tablet BID x7 days. Will recheck on Thursday 3/2/23
Age: 7.0
Sex: F
Vaccine: HEP
Symptoms: Extra dose administered
Clinical narrative: Dose #4 given inadvertenly,  Vaccine record was not correct at the time of administration. The Hepatitis doses had been left off the transfer of the Mother's copy to our clinic copy by the front desk office staff
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anaemia, Asthenia, Clostridium difficile colitis, Cough
Clinical narrative: Hospitalized 7/7/22-7/11/22 AKI, hyperkalemia, weakness, decreased appetite, dehydration, UTI, sepsis, respiratory failure, PNA, cough, SOB, + fecal occult blood, anemia, malaise, c-diff,
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dehydration, Dyspnoea, Hyperkalaemia, Malaise
Clinical narrative: Hospitalized 7/7/22-7/11/22 AKI, hyperkalemia, weakness, decreased appetite, dehydration, UTI, sepsis, respiratory failure, PNA, cough, SOB, + fecal occult blood, anemia, malaise, c-diff,
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Occult blood positive, Pneumonia, Respiratory failure, Sepsis, Urinary tract infection
Clinical narrative: Hospitalized 7/7/22-7/11/22 AKI, hyperkalemia, weakness, decreased appetite, dehydration, UTI, sepsis, respiratory failure, PNA, cough, SOB, + fecal occult blood, anemia, malaise, c-diff,
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cerebrovascular accident, Echocardiogram, Magnetic resonance imaging
Clinical narrative: stroke
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Computerised tomogram thorax normal, Dyspnoea
Clinical narrative: Patient is a 69 y.o. female patient of local MD with history of COPD with previous use of oxygen at home, tobacco use disorder, hyperlipidemia, presented to Hospital with shortness of breath and found to have COVID-19 virus infection.   Acute Respiratory Failure with Hypoxia and Hypercapnia  Initially on BiPAP ; weaned down to nasal cannula 4L Last VBG 7.26/56.5/30 on high flow 30/50 Continue to wean off O2 as tolerated to baseline 3L DuoNebs as needed. Improving   Covid-19 Virus Infection with pneumonia Date of onset of symptoms: A week ago Symptoms present on admission: Shortness of breath Date of covid positive test: 1/13/2023 Vaccination status: vaccinated Imaging: CT pulmonary artery; no evidence of pulmonary embolism.  Multifocal pneumonia in the lingula and lower lobes Oxygen requirements on admission: BiPAP Current oxygen requirements: 4L NC. Used 3L at baseline  Continue to wean to 3L baseline. Feeling much better. Medical therapy: steroids. Abx stopped. Consultants following:  eID Incentive spirometry, inhalers. Encouraging proning as tolerated Medically much better, ok to dc today once back on 3L baseline O2.   Suspected PNA CT chest as above, PCT wnl. Ok to stop abx, await ID recs   Hypertension Continue home toprol and cardizem. Stable BP   Tobacco use disorder, dependence moderate Spent 5 minutes counseling patient on cessation   Pulmonary nodule, solid 8 mm in size Recommend CT in 6 to 12 months   Hyperlipidemia Continue home simvastatin   History of rib fracture Subacute right lower lateral rib fracture noted on x-ray Continue to monitor   Anxiety Disorder Benzo dependence Chronically on Xanax, resumed
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Procalcitonin normal, Pulmonary mass, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 69 y.o. female patient of local MD with history of COPD with previous use of oxygen at home, tobacco use disorder, hyperlipidemia, presented to Hospital with shortness of breath and found to have COVID-19 virus infection.   Acute Respiratory Failure with Hypoxia and Hypercapnia  Initially on BiPAP ; weaned down to nasal cannula 4L Last VBG 7.26/56.5/30 on high flow 30/50 Continue to wean off O2 as tolerated to baseline 3L DuoNebs as needed. Improving   Covid-19 Virus Infection with pneumonia Date of onset of symptoms: A week ago Symptoms present on admission: Shortness of breath Date of covid positive test: 1/13/2023 Vaccination status: vaccinated Imaging: CT pulmonary artery; no evidence of pulmonary embolism.  Multifocal pneumonia in the lingula and lower lobes Oxygen requirements on admission: BiPAP Current oxygen requirements: 4L NC. Used 3L at baseline  Continue to wean to 3L baseline. Feeling much better. Medical therapy: steroids. Abx stopped. Consultants following:  eID Incentive spirometry, inhalers. Encouraging proning as tolerated Medically much better, ok to dc today once back on 3L baseline O2.   Suspected PNA CT chest as above, PCT wnl. Ok to stop abx, await ID recs   Hypertension Continue home toprol and cardizem. Stable BP   Tobacco use disorder, dependence moderate Spent 5 minutes counseling patient on cessation   Pulmonary nodule, solid 8 mm in size Recommend CT in 6 to 12 months   Hyperlipidemia Continue home simvastatin   History of rib fracture Subacute right lower lateral rib fracture noted on x-ray Continue to monitor   Anxiety Disorder Benzo dependence Chronically on Xanax, resumed
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, COVID-19, Cardiac stress test abnormal, Chronic kidney disease
Clinical narrative: Patient is a 81 y.o. male patient of (name withheld), MD with a history of myasthenia gravis admitted for COVID-19 infection and urinary tract infection.  ID consult appreciated patient completed remdesivir.  Remains afebrile during the hospitalization patient was found to have acute on chronic renal failure which was treated with IV hydration Lasix being discontinued.  Blood pressure was running high all throughout initially patient was reluctant to get any new blood pressure medication finally agreed to go home with Norvasc.  We will follow-up as outpatient.   Discharge Diagnoses: Urinary tract infection Assessment & Plan Urine growing Proteus pansensitive.  Being discharged on cephalexin 500 3 times daily for a week   * COVID-19 virus infection Assessment & Plan Patient was hypoxemic on admission.  CT chest negative for pulm pulmonary embolism or any infiltrate.   Has completed remdesivir now asymptomatic  Elevated troponin Assessment & Plan Patient's troponin slightly elevated probably secondary to type II MI/demand ischemia.   Patient's nuclear stress test done February 2022 negative for inducible ischemia however did show drop in ejection fraction from 66 from a previous echocardiogram to 34.  We will do a repeat 2D echo.   Hypernatremia Assessment & Plan Resolved   Acute renal failure with acute tubular necrosis superimposed on stage 3a chronic kidney disease (HCC) Assessment & Plan Acute component resolved with IV hydration.  Plan to hold Lasix reevaluate as outpatient   Myasthenia (HCC) Assessment & Plan Continue home medication   Essential hypertension Assessment & Plan Not under control amlodipine added discussed about benefit risk side effect including leg edema.   Acquired hypothyroidism Assessment & Plan Continue home medication of Synthroid
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax normal, Condition aggravated, Culture urine positive, Echocardiogram, Ejection fraction decreased
Clinical narrative: Patient is a 81 y.o. male patient of (name withheld), MD with a history of myasthenia gravis admitted for COVID-19 infection and urinary tract infection.  ID consult appreciated patient completed remdesivir.  Remains afebrile during the hospitalization patient was found to have acute on chronic renal failure which was treated with IV hydration Lasix being discontinued.  Blood pressure was running high all throughout initially patient was reluctant to get any new blood pressure medication finally agreed to go home with Norvasc.  We will follow-up as outpatient.   Discharge Diagnoses: Urinary tract infection Assessment & Plan Urine growing Proteus pansensitive.  Being discharged on cephalexin 500 3 times daily for a week   * COVID-19 virus infection Assessment & Plan Patient was hypoxemic on admission.  CT chest negative for pulm pulmonary embolism or any infiltrate.   Has completed remdesivir now asymptomatic  Elevated troponin Assessment & Plan Patient's troponin slightly elevated probably secondary to type II MI/demand ischemia.   Patient's nuclear stress test done February 2022 negative for inducible ischemia however did show drop in ejection fraction from 66 from a previous echocardiogram to 34.  We will do a repeat 2D echo.   Hypernatremia Assessment & Plan Resolved   Acute renal failure with acute tubular necrosis superimposed on stage 3a chronic kidney disease (HCC) Assessment & Plan Acute component resolved with IV hydration.  Plan to hold Lasix reevaluate as outpatient   Myasthenia (HCC) Assessment & Plan Continue home medication   Essential hypertension Assessment & Plan Not under control amlodipine added discussed about benefit risk side effect including leg edema.   Acquired hypothyroidism Assessment & Plan Continue home medication of Synthroid
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Essential hypertension, Hypernatraemia, Hypertension, Hypoxia, Myocardial ischaemia
Clinical narrative: Patient is a 81 y.o. male patient of (name withheld), MD with a history of myasthenia gravis admitted for COVID-19 infection and urinary tract infection.  ID consult appreciated patient completed remdesivir.  Remains afebrile during the hospitalization patient was found to have acute on chronic renal failure which was treated with IV hydration Lasix being discontinued.  Blood pressure was running high all throughout initially patient was reluctant to get any new blood pressure medication finally agreed to go home with Norvasc.  We will follow-up as outpatient.   Discharge Diagnoses: Urinary tract infection Assessment & Plan Urine growing Proteus pansensitive.  Being discharged on cephalexin 500 3 times daily for a week   * COVID-19 virus infection Assessment & Plan Patient was hypoxemic on admission.  CT chest negative for pulm pulmonary embolism or any infiltrate.   Has completed remdesivir now asymptomatic  Elevated troponin Assessment & Plan Patient's troponin slightly elevated probably secondary to type II MI/demand ischemia.   Patient's nuclear stress test done February 2022 negative for inducible ischemia however did show drop in ejection fraction from 66 from a previous echocardiogram to 34.  We will do a repeat 2D echo.   Hypernatremia Assessment & Plan Resolved   Acute renal failure with acute tubular necrosis superimposed on stage 3a chronic kidney disease (HCC) Assessment & Plan Acute component resolved with IV hydration.  Plan to hold Lasix reevaluate as outpatient   Myasthenia (HCC) Assessment & Plan Continue home medication   Essential hypertension Assessment & Plan Not under control amlodipine added discussed about benefit risk side effect including leg edema.   Acquired hypothyroidism Assessment & Plan Continue home medication of Synthroid
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Proteus test positive, Renal tubular necrosis, Troponin increased, Urinary tract infection
Clinical narrative: Patient is a 81 y.o. male patient of (name withheld), MD with a history of myasthenia gravis admitted for COVID-19 infection and urinary tract infection.  ID consult appreciated patient completed remdesivir.  Remains afebrile during the hospitalization patient was found to have acute on chronic renal failure which was treated with IV hydration Lasix being discontinued.  Blood pressure was running high all throughout initially patient was reluctant to get any new blood pressure medication finally agreed to go home with Norvasc.  We will follow-up as outpatient.   Discharge Diagnoses: Urinary tract infection Assessment & Plan Urine growing Proteus pansensitive.  Being discharged on cephalexin 500 3 times daily for a week   * COVID-19 virus infection Assessment & Plan Patient was hypoxemic on admission.  CT chest negative for pulm pulmonary embolism or any infiltrate.   Has completed remdesivir now asymptomatic  Elevated troponin Assessment & Plan Patient's troponin slightly elevated probably secondary to type II MI/demand ischemia.   Patient's nuclear stress test done February 2022 negative for inducible ischemia however did show drop in ejection fraction from 66 from a previous echocardiogram to 34.  We will do a repeat 2D echo.   Hypernatremia Assessment & Plan Resolved   Acute renal failure with acute tubular necrosis superimposed on stage 3a chronic kidney disease (HCC) Assessment & Plan Acute component resolved with IV hydration.  Plan to hold Lasix reevaluate as outpatient   Myasthenia (HCC) Assessment & Plan Continue home medication   Essential hypertension Assessment & Plan Not under control amlodipine added discussed about benefit risk side effect including leg edema.   Acquired hypothyroidism Assessment & Plan Continue home medication of Synthroid
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash maculo-papular
Clinical narrative: Reported at 1852 on 6/23/2022 a rash of new onset after PM shower.  The rash is located on her back and abdomen and in skin folds of torso.  No signs of itching or discomfort.  Reports no changes in soaps, lotions, detergent, bedding or foods.  No new meds. except a covid booster on 6/21/2022 at 0744. Skin: rash was scattered pink, flat in appearance to her upper and lower back, various sites to the abdomen and skin folds. Per RN that rash is pick unraised to her abdomnen and under the breast area, the shape is irregular and sporadic with no regular board.  Patient was seen on 6/24/22 describes a maculopapular rash noted to lower back and abdomen.  Onset of symptoms occured the evening of 6/23/2022.  Treatment:Bendaryl 25mg once Benadryl 25mg q6hrs while awake for 2 days. Rash resolution on 6/26/2022
Age: 64.0
Sex: F
Vaccine: COVID19-2, PNC20
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Covid booster not viable due to improper temperature storage.
Age: 16.0
Sex: M
Vaccine: DTAP
Symptoms: Unevaluable event
Clinical narrative: none
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Pruritus, Skin exfoliation, Skin lesion, Transient acantholytic dermatosis
Clinical narrative: Pretty soon after receiving my first Moderna Vaccine I noticed a few spots, but have issues with eczema so didn't think much of it. After my second dose I noticed the spots spread quickly across my abdomen, sides (flanks), and lower back. It often encroaches on the top of my buttocks and upper back. It has been ongoing and persistent for 2 years with no reprieve. My dermatologist treated it first with triamcinolone, which only made things worse over time. It made my skin very scaly and even more itchy.  He then decided it was best to biopsy and the results came back as Grovers Disease. Next he tried prednisone and things got much, much worse that I had to expedite my taper. I had significant symptoms from prednisone including a lot of hair loss from my scalp. I have since stopped all treatments as it only made the condition more unbearable.   My current at home treatment is to use a sensitive soap or shea butter soap, Sarna sensitive lotion and ending with petroleum jelly as an occlusive to lock in the moisture. Although persistent, at times it can really calm down, but then then flare up with no warning and no changes in my treatment.  I began researching online about a year after onset and only saw one study linking grovers disease to Moderna -- it said Acantholytic dyskeratosi was mimicking grovers disease in Moderna patients. Then yesterday I saw an online thread where several women had mentioned the onset of grovers disease after taking Pfizer as well. I realized that I'm not unrealistic to link the disease with the vaccine and decided to report my symptoms in hopes they can find the connection and find reasonable cure or treatment plan to combat this vaccine side effect.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 02/12/23 presents to ED for "fatigue". PMHx of "MS, DM II, HTN"
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Patient received first COVID vaccine on 11-29-22 which was Moderna at another facility. He came today to complete primary series and was given Pfizer as his second dose. Patient had no adverse event at time of vaccine today.
Age: 7.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: Given Kinrix and should have received TDAP and Polio seperate
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 02/12/23 presents to EC ED for "shortness of breath". PMHx of "emphysema on 3.5 L O2 NC (4 L at bedtime), non-insulin-dependent diabetes mellitus, hypertension, dyslipidemia and BPH"
Age: 52.0
Sex: F
Vaccine: COVID19-2, FLUR4
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Syncope
Clinical narrative: 02/12/23 presents to ED for "Syncopal episode". PMHx of "down syndrome, dementia, hypothyroidism, subdural hematoma s/p evacuation (12/9/21) , sinus bradycardia, orthostatic hypotension"
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Blood test, Electrocardiogram, Electrocardiogram ambulatory, Palpitations
Clinical narrative: I had vaccination on 02/22/2022. I started to experience with heart palpitations and atrial fibrillation in 07/2022 and monitored vitals with watch. I contacted my primary doctor who referred me to a cardiologist. I went to the emergency room on 10/17/2022 for atrial fibrillation. I wore a Holter monitor for two weeks and was seen by cardiology 02/7/2023. I have a follow up appointment on March 7th 2023 for possible pacemaker.
Age: 50.0
Sex: M
Vaccine: COVID19-2, FLUR4
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper storage.
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccine administered, no adverse symptoms reported.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blister, Herpes zoster, Laboratory test, Neuralgia, Pain of skin
Clinical narrative: She got her vaccine, had no problems until 1/26/23 when she noticed that she had a rash on her right shoulder blade.  Then the next day she had a bunch of blisters on the shoulder blade.  Then it became like 50 blisters and one dense blister and it was on the weekend and within the 2 days by Monday she had a big red blotch and after the blotch it was almost becoming blisters on crack as they forming so fast that the redness turned into them.  She has had friends that had shingles before and they said that they had never seen anything like it.  She is still recovering from he blisters even though she has recovered from it.  It went over her chest, to her armpit, her inner arm, forearm.  She went to see her PCP and she gave her a prescription to pick up, the rash proceeded to take over her body and went to the ER and they were going to hospitalize her for 10 days.  She was then given Valtrex IV and put her on really strong RX like 1 gram t.i.d. of Valtrex and then Gabapentin for the nerve pain.  She had mentioned to her sister that she thought she had singles, and had the shingles vaccine 2 years ago.  She is a nurse so she figured it was shingles, and then the PCP gave her medicine and then ER confirmed that she had shingles.  They called the infectious disease doctor and treated her with the IV Valtrex and then sent her home on it as well.  After she finished the prescription that since it was so severe to let them know if she didn't get rid of the blisters to let them know and she was extended it and now on it prophylactically for 6 months.  They have all crusted over and her skin is still healing, still has some tenderness and dark areas on her skin and hoping that is going to lighten up and having nerve pain as well so continues to take the Gabapentin.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash, Rash macular, Scab, Skin discolouration
Clinical narrative: She got her vaccine, had no problems until 1/26/23 when she noticed that she had a rash on her right shoulder blade.  Then the next day she had a bunch of blisters on the shoulder blade.  Then it became like 50 blisters and one dense blister and it was on the weekend and within the 2 days by Monday she had a big red blotch and after the blotch it was almost becoming blisters on crack as they forming so fast that the redness turned into them.  She has had friends that had shingles before and they said that they had never seen anything like it.  She is still recovering from he blisters even though she has recovered from it.  It went over her chest, to her armpit, her inner arm, forearm.  She went to see her PCP and she gave her a prescription to pick up, the rash proceeded to take over her body and went to the ER and they were going to hospitalize her for 10 days.  She was then given Valtrex IV and put her on really strong RX like 1 gram t.i.d. of Valtrex and then Gabapentin for the nerve pain.  She had mentioned to her sister that she thought she had singles, and had the shingles vaccine 2 years ago.  She is a nurse so she figured it was shingles, and then the PCP gave her medicine and then ER confirmed that she had shingles.  They called the infectious disease doctor and treated her with the IV Valtrex and then sent her home on it as well.  After she finished the prescription that since it was so severe to let them know if she didn't get rid of the blisters to let them know and she was extended it and now on it prophylactically for 6 months.  They have all crusted over and her skin is still healing, still has some tenderness and dark areas on her skin and hoping that is going to lighten up and having nerve pain as well so continues to take the Gabapentin.
Age: 30.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccine administered. no adverse symptoms reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/2/21 Lot# 030L20A;  Moderna 3/30/21 Lot# 002B21A;  Moderna 11/17/21 Lot# 004F21A;
Age: 25.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccine administered. no adverse symptoms reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after one dose Janssen vaccines
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccine administered. no adverse symptoms reported.
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccine administration. no adverse symptoms reported.